ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
0 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
ces
|
255 |
83K |
4 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
255
|
83K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
10 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Why Meso is pumping today?
|
|
ces
|
109 |
43K |
11 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
109
|
43K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
ces
|
905 |
286K |
7 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
905
|
286K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
ces
|
93 |
35K |
5 |
30/01/21 |
30/01/21 |
ASX - By Stock
|
93
|
35K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
ces
|
221 |
66K |
1 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
221
|
66K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ces
|
17K |
6.7M |
30 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
17K
|
6.7M
|
30
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ces
|
10K |
3.0M |
3 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Attention: Dr. Silviu Itescu
|
|
ces
|
43 |
20K |
0 |
02/01/21 |
02/01/21 |
ASX - By Stock
|
43
|
20K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
ces
|
416 |
132K |
4 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
416
|
132K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
ces
|
192 |
86K |
3 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
192
|
86K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
ces
|
192 |
86K |
4 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
192
|
86K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
6 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
ces
|
344 |
180K |
4 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
344
|
180K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
ces
|
344 |
180K |
72 |
12/12/20 |
12/12/20 |
ASX - By Stock
|
344
|
180K
|
72
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
3 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
2 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
4 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
24 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
5 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
9 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
2 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
12 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD
|
|
ces
|
139 |
72K |
15 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
139
|
72K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
ces
|
416 |
132K |
0 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
416
|
132K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
ces
|
416 |
132K |
0 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
416
|
132K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
1 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
7 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
8 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
9 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Hart-Scott-Rodino Antitrust Improvements Act
|
|
ces
|
20 |
7.5K |
0 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
20
|
7.5K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
ces
|
392 |
158K |
4 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
392
|
158K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP
|
|
ces
|
111 |
55K |
57 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
111
|
55K
|
57
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Sale of PNG Interests
|
|
ces
|
69 |
23K |
3 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
69
|
23K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Sale of PNG Interests
|
|
ces
|
69 |
23K |
1 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
69
|
23K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
ces
|
13K |
5.0M |
1 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
ces
|
635 |
278K |
3 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
278K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
12 |
5.2K |
3 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
12
|
5.2K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
12 |
5.2K |
3 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
12
|
5.2K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Investigation into PNG transaction concluded
|
|
ces
|
14 |
7.9K |
5 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
14
|
7.9K
|
5
|
|
ASX - By Stock
|
STO |
Re:
Long Term Future of Santos
|
|
ces
|
432 |
238K |
3 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
432
|
238K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
23 |
11K |
2 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
23
|
11K
|
2
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
23 |
11K |
2 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
23
|
11K
|
2
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
23 |
11K |
1 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
23
|
11K
|
1
|
|
ASX - By Stock
|
HZN |
Re:
Ann: Quarterly Activities Report
|
|
ces
|
23 |
11K |
0 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
23
|
11K
|
0
|
|
ASX - By Stock
|
STO |
Re:
Ann: Change of Director's Interest Notice
|
|
ces
|
3 |
2.6K |
3 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
3
|
2.6K
|
3
|
|
ASX - By Stock
|
HZN |
Re:
News: HZN Horizon Oil Updates On Convid-19 Impact
|
|
ces
|
33 |
13K |
0 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
33
|
13K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
News: HZN Horizon Oil Updates On Convid-19 Impact
|
|
ces
|
33 |
13K |
0 |
05/04/20 |
05/04/20 |
ASX - By Stock
|
33
|
13K
|
0
|
|
ASX - By Stock
|
HZN |
Re:
News: HZN Horizon Oil Updates On Convid-19 Impact
|
|
ces
|
33 |
13K |
0 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
33
|
13K
|
0
|
|